GxP Auditing Services Market Share Grows Amid Regulatory Tightening and Compliance Demands Across Life Sciences | Valuates Reports

GxP Auditing Services Market Size
The global market for GxP Auditing Services was valued at US$ 731 million in the year 2024 and is projected to reach a revised size of US$ 1008 million by 2031, growing at a CAGR of 5.4% during the forecast period.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-33H19149/Global_GxP_Auditing_Services_Market_Research_Report_2025

The GxP Auditing Services Market is experiencing robust growth as life sciences companies prioritize compliance and quality assurance amid tightening global regulatory standards. These services ensure adherence to Good Practices (GxP) guidelines-including Good Manufacturing Practices (GMP), Good Laboratory Practices (GLP), and Good Clinical Practices (GCP)-which are critical across pharma, biotech, and medical device industries.

By type, Onsite Services hold a dominant market share due to their effectiveness in delivering in-depth, facility-specific compliance audits and regulatory risk assessments. However, Remote Services are rapidly gaining traction, driven by digital transformation, cost-efficiency, and accessibility in post-COVID auditing environments. Hybrid Services, combining physical site visits with virtual assessments, are emerging as a preferred model, offering both flexibility and depth.

By application, the Pharmaceutical segment leads the market, driven by stringent FDA, EMA, and MHRA mandates. Biotechnology follows closely due to the complexity and innovation in biologics, gene therapies, and cell-based treatments. Medical Devices also represent a significant share, influenced by evolving MDR and ISO standards. Meanwhile, Nutrients and Supplements and Others (such as cosmetics and CROs) are showing steady growth, with increased scrutiny on manufacturing processes and labeling accuracy.

As the global life sciences ecosystem continues to expand and regulations become more rigorous, demand for comprehensive, technology-enabled GxP auditing solutions is set to surge.

Segment by Type

• Onsite Services
• Remote Services
• Hybrid Services

Segment by Application
• Pharmaceuticals
• Biotechnology
• Medical Devices
• Nutrients and Supplements
• Others

By Company

GXP Engaged Auditing Services, Clinical Pathways, Propharma, Orbis Clinical, FDA, Pharmatek, Pharmalex (Cencora), ZigZag, DSI, Apotech, ProductLife, CRQA, Pearl Pathways, RiverArk, DADA, Freyr, Advarra

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-33H19149/global-gxp-auditing-services

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.